Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
18 Nov 2026Chengdu Zenitar Biomedical Technology Co., LtdAustraliaA Phase I Clinical Study of Oral ZL-65 Tablets in Healthy and Obese Participants With Cardiovascular RiskPhase 1Not Yet Recruiting18 Nov 2026Shanghai Henlius BiotechAustralia, ChinaA Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX49 in Advanced/Metastatic Solid TumorsPhase 1Not Yet Recruiting18 Nov 2026Sleep Cycle ABAustraliaDevelopment of the Sleep Cycle App's Tracking Abilities of Sleep and Sleep BehaviorsCompleted17 Nov 2026Aerys BiosciencesAustraliaFirst-in-Human Study of ABS-169 in Healthy VolunteersPhase 1Not Yet Recruiting17 Nov 2026AstraZenecaUnited States, Argentina, AustraliaA Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCPhase 2Not Yet Recruiting17 Nov 2026NS Pharma, Inc.United States, Australia, CanadaA Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyPhase 2Enrolling By Invitation16 Nov 2026CStone PharmaceuticalsAustralia, ChinaA First-in-human (FIH), Open-label, and Multi-center Study of CS5006 in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting13 Nov 2026Shanghai Henlius BiotechAustralia, ChinaA Phase I Study of HLX109 in Healthy ParticipantsPhase 1Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting10 Nov 2026MedicureUnited States, AustraliaContinuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyPhase 3Recruiting9 Nov 2026Boehringer IngelheimUnited States, Australia, JapanA Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D MutationPhase 1Not Yet Recruiting6 Nov 2026Dartsbio Pharmaceuticals Ltd.AustraliaPhase 1/2 Study of DS010 in Advanced Cancer Patients With CachexiaPhase 1, Phase 2Recruiting6 Nov 2026Rapport Therapeutics Inc.AustraliaStudy Designed to Evaluate the Safety, Tolerability, and PK of RAP-219 Formulated as an Long Acting Injectable.Phase 1Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting4 Nov 2026Luminance Biosciences IncAustraliaSafety and Biodistribution of [68Ga]Ga DOTA-5G in Subjects With Metastatic Breast Cancer (BC)Phase 1Not Yet Recruiting4 Nov 2026Vexev Pty LtdAustraliaComparison of VxWave and Standard Ultrasound Measurements of Blood Vessels in the ArmNot applicableNot Yet Recruiting29 Oct 2026Beeline Medicines CorporationAustraliaA Phase 1, First-in-Human Trial of BLN-481in Healthy Adult ParticipantsPhase 1Recruiting29 Oct 2026Cibus Therapeutics, Inc.AustraliaA Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of CBT-248 in Healthy Adult ParticipantsPhase 1Recruiting29 Oct 2026Mabsoft Therapeutics (Shanghai) Co., Ltd.AustraliaPhase Ia Study of MST-931 in Healthy Adult SubjectsPhase 1Recruiting29 Oct 2026North Immunology Inc.AustraliaA Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic DermatitisPhase 1Not Yet Recruiting28 Oct 2026Cajal Therapeutics Inc.AustraliaStudy of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney DiseasePhase 1Not Yet Recruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting28 Oct 2026Helixon Biotechnology (Suzhou) Co., LtdAustraliaStudy of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate AsthmaPhase 1Not Yet Recruiting26 Oct 2026Editas Medicine, Inc.AustraliaEDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)Phase 1, Phase 2Not Yet Recruiting23 Oct 2026AN2 Therapeutics, IncAustraliaPhase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraPhase 2Not Yet Recruiting22 Oct 2026iBio, Inc.AustraliaA Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.Phase 1Not Yet Recruiting22 Oct 2026Serum Institute of India Pvt. Ltd.AustraliaClinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) VaccinePhase 1, Phase 2Not Yet Recruiting21 Oct 2026Antido Therapeutics (Australia) Pty LtdAustraliaSafety and Tolerability of AT-0174 in Adults With Advanced Solid TumorsPhase 1Completed// How AOS uses this